ITC Blocks Chinese Biotech Imports In Win For Ventria
IP Law 360
SEPTEMBER 13, 2022
International Trade Commission has blocked four biotechnology companies from importing a vaccine ingredient from China that infringes a cell culture patent held by Ventria Bioscience.
Let's personalize your content